Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate
IntroductionIn one third of all patients with epilepsy, seizure freedom is not achieved through anti-seizure medication (ASM). These patients have an increased risk of earlier death, poorer cognitive development, and reduced quality of life. Cenobamate (CNB) has recently been approved as a promising...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2022-07-01
|
| Serie: | Frontiers in Neurology |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fneur.2022.950171/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|